Christopher P. Cannon

Author

Also Known As

C Cannon, C P Cannon, C. Cannon, C. P. Cannon, CHRISTOPHER P. CANNON, Casey Cannon, Christopher Cannon, Christopher P Cannon, Christopher P. Cannon, Christopher Paul Cannon

163

Publications

18.8K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Thrombolysis in Myocardial Infarction Study Group University of Sheffield Uppsala University Clinical Research Institute

About

Christopher P. Cannon is an author at Brigham and Women's Hospital specializing in medicine, cardiovascular disease, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	30	3.8K
2	Emergency Medicine	13	15	2K
3	Public Health	10	10	1.4K
4	Health Sciences	2	2	67
5	Diagnostic Sciences	1	1	33

Christopher P. Cannon

Publications

16.1K

Citations

H-Index

Page 1

	Year	Citations
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes Lars Wallentin, Richard C. Becker, Andrzej Budaj, New England Journal of Medicine	2009	7K
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation Marc S. Sabatine, Christopher P. Cannon, C. Michael Gibson, New England Journal of Medicine	2005	1.9K
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes31This document was approved by the American College of Cardiology Board of Trustees in November 2001.32When citing this document, the American College of Cardiology would appreciate the following citation format: Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van de Werf FJJ, Weintraub WS. ACC Key Elements and Data Definitions for Measuring the Clinical Management and Outcomes of Patients with Acute Coronrary Syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 2001;38:2114–30.33This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). Reprints of this document may be purchased for $5.00 each by calling 1-800-253-4636 or by writing to the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, Maryland 20814-1699. © 2001 by the American College of Cardiology Christopher P. Cannon, Alexander Battler, Ralph G. Brindis, Journal of the American College of Cardiology	2001	685
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery Claes Held, Nils Åsenblad, Jean Pierre Bassand, Journal of the American College of Cardiology ThrombosisCardiorenal SyndromesCardiovascular DiseaseCoronary Artery DiseaseVascular Surgery	2010	528
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Christopher P. Cannon, Steen Husted, Robert A. Harrington, Journal of the American College of Cardiology Molecular PharmacologyThrombosisCardiovascular DiseaseInitial EfficacyCoronary Artery Disease	2007	490
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes Robert F. Storey, Steen Husted, Robert A. Harrington, Journal of the American College of Cardiology ThrombopoiesisThrombosisPlatelet Aggregation InhibitorsCardiovascular DiseaseBlood Platelet	2007	484
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial Kenneth W. Mahaffey, Daniel Wojdyla, Kevin Carroll, Circulation	2011	434
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Stefan James, Andrzej Budaj, Philip E. Aylward, Circulation	2010	399
Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention Matthew J. Price, Dominick J. Angiolillo, Paul S. Teirstein, Circulation	2011	396
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes Robert F. Storey, Dominick J. Angiolillo, Shankar B. Patil, Journal of the American College of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletAtherosclerosis	2010	365

Page 1